Skip to main content
Transparency data

Clinical trials for medicines: authorisation assessment performance

Data on the time taken by the MHRA to assess clinical trial applications and substantial amendments.

Updates to this page

From:
Medicines and Healthcare products Regulatory Agency
Published:
12 February 2015
Last updated:
15 May 2023
Show all updates

  1. The document 'Clinical trials data for medicines' has been updated.

  2. PDF updated (Clinical trials for medicines: authorisation assessment performance).

  3. Updated clinical trials data for medicines

  4. Updated stats to October 2021

  5. Updated clinical trials data for medicines

  6. Updated clinical trials data for medicines pdf

  7. Updated with Clinical trials data for medicines July 2021

  8. Updated the Clinical trials data for medicines data.

  9. Updated 'Clinical trials data for medicines'

  10. Published March 2021 data for authorisation assessment performance of clinical trials for medicines

  11. Published March 2020 data for authorisation assessment performance of clinical trials for medicines

  12. Updated the downloadable CTU metrics

  13. Updated CTU metrics to August 2019

  14. Updated CTU metrics to July 2019 version

  15. Published clinical trials for medicines data for May 2019.

  16. Added clinical trials data for February 2019.

  17. Updated Clinical trials for medicines attachment

  18. We uploaded the December 2018 updates.

  19. Updated CTU metrics (attachment)

  20. New document with analytics has been added.

  21. Updated Clinical trials data for medicines document

  22. Uploaded new clinical trials data for medicines document.

  23. Updated CTU metrics for medicines.

  24. Added Feb 2018 CTU PDF

  25. CTU metrics for December 2017 added to the page.

  26. Updated attachment for October and November

  27. CTU metrics for September added to the page.

  28. CTU metrics for August added to the page.

  29. CTU metrics up to July 2017 added to the page.

  30. CTU metrics updated for June 2017

  31. Clinical Trials metrics for May 2017 added to the page.

  32. Updated clinical trials data added for March

  33. Updated metrics for clinical trials

  34. updated metrics

  35. Added November updates for CTU metrics.

  36. Latest CTU metrics for October added.

  37. Updated metrics

  38. updated data

  39. Added July updates for CTU metrics.

  40. Added June updates for CTU metrics

  41. Added May updates for CTU metrics

  42. Additional data up to March 2016

  43. Updated: Clinical trials for medicines: authorisation assessment performance

  44. Clinical trials for medicines: authorisation assessment performance (April 2014 to March 2015)

  45. Clinical trials authorisation assessment performance has been updated.

  46. First published.

This publication was withdrawn on

The MHRA now publishes performance metrics for clinical trials on a monthly basis with other performance data, in one place:

https://www.gov.uk/government/publications/mhra-performance-data-for-assessment-of-clinical-trials-and-established-medicines.

Documents

Clinical trials data for medicines

PDF, 512 KB, 34 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This data sets out the number of applications assessed by the MHRA, split by phase and commercial and non-commercial sponsors.

The phase of application matches with the phases described in The Medicines (Products for Human Use) (Fees) Regulations and not the phase described in the application form.

Data is also provided for substantial amendments, split by phase. Monthly data is determined by the date initial assessment was completed, and not the receipt date.

Sign up for emails or print this page